R-10015
R-10015, a broad-spectrum antiviral compound for HIV infection, acts as a potent and selective inhibitor of LIM domain kinase (LIMK) and binds to the ATP-binding pocket, with an IC50 of 38 nM for human LIMK1[1].
Product Specifications
CAS Number
[2097938-51-5]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
LIM Kinase (LIMK) ; Reverse Transcriptase
Type
Reference compound
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/r-10015.html
Purity
99.72
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=C2NC(C3CCN(C4=C5C(NC=C5Cl)=NC=N4)CC3)=NC2=C1)OC
Molecular Formula
C20H19ClN6O2
Molecular Weight
410.86
Precautions
H302, H315, H319, H335
References & Citations
[1]Yi F, et al. Discovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1. J Virol. 2017 Jun 9;91 (13) . pii: e02418-16.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
LIMK1
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Shewanella woodyi Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp)
Recombinant Shewanella woodyi Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp)
Recombinant Shewanella woodyi Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp)
Recombinant Shewanella woodyi Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp)
Recombinant Shewanella woodyi Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp)